MPD: Project measures / variables set: Mills1 late

Project measures / variables set: Mills1 late_apoptotic

ID, description, units	MPD:25211 late_apoptotic late apoptotic splenocytes [%]
Measures	• 6mo • 12mo • 20mo
Data set, strains	Mills1 inbred 30 strains sex: both
Procedure	apoptosis assessment
Comparison	aging-study, multiple cohorts
Ontology mappings	VT:0009340 splenocyte apoptosis trait MA:0000141 spleen MP:0009340 abnormal splenocyte apoptosis

Values Means Δ Means Z-scores

Graph Type Points Bars

Dimensions Width: × Height: px

Plot Options Hide Error Bars Strains on X-axis

Data Type:

Dimensions Height: px

Toggle Series

Plot Options Show Standard Error Show Point Labels Flip Axes Shared Tooltip Connect Gaps

Mills1 - late apoptotic splenocytes

ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary

Factor	DF	Sum of squares	Mean sum of squares	F value	p-value (Pr>F)
age	2	22.7436	11.3718	7.9922	0.0009
age:sex	2	18.0013	9.0006	6.3257	0.0034
age:sex:strain	6	23.2313	3.8719	2.7212	0.0223
age:strain	6	8.9547	1.4925	1.0489	0.4048
Residuals	53	75.4117	1.4229
sex	1	4.0407	4.0407	2.8399	0.0978
sex:strain	3	9.9773	3.3258	2.3374	0.0841
strain	3	47.2864	15.7621	11.0778	< 0.0001

Q-Q normality assessment based on residuals

INDIVIDUAL MEASURES

Project	ID		Treatment	Measure / Variable Description	Panel	Strains tested	Sex	Age
Mills1	25211	apoptosis assessment	(none)	late apoptotic splenocytes [%] at age 6mo late_apoptotic_M06	inbred	7	both	26wks
Mills1	25212	apoptosis assessment	(none)	late apoptotic splenocytes [%] at age 12mo late_apoptotic_M12	inbred	29	both	52wks
Mills1	25213	apoptosis assessment	(none)	late apoptotic splenocytes [%] at age 20mo late_apoptotic_M20	inbred	28	both	87wks